Credit: Canva
Yoga is frequently studied for its potential to relieve chronic low back pain, a condition that in 2020 affected 619 million people globally. Moreover, severe back pain can trigger conditions like arthritis, herniated discs, spinal stenosis, and infections. However, an Italian research team specializing in rehabilitative medicine has made an interesting discovery on yoga's positive impact on lower back pain.
Yoga poses included in the study, such as Downward-Facing Dog, Pigeon Pose, Child’s Pose, and Cobra Pose, were held for five breaths each. Dr. Alessandro de Sire, one of the study authors, highlighted that these poses can relax muscles and improve mobility. Jivana Heyman, a yoga therapist, added that hip flexion poses help increase the range of motion without overly engaging the lower back.
This study adds to growing evidence supporting yoga as a viable treatment for low back pain. For those interested in starting yoga, experts recommend seeking classes like "Gentle Yoga" or "Accessible Yoga," where instructors can adapt poses to individual needs.
While more research is needed, this study highlights yoga as a valuable addition to managing low back pain, combining physical relief with stress reduction and nervous system regulation.
Yoga is the oldest form of exercise and traces its roots back to ancient India. The word "yoga" comes from the Sanskrit word "yuj," which means "to yoke" or "to bind." Interestingly, yoga incorporates physical postures (asanas), breathing techniques (pranayama), and meditation together. While spirituality lists various benefits of yoga, scientific research into it is still at a preliminary stage. However, numerous studies have indicated that it has a significant positive impact on a person's physical and mental health.
Yoga offers diverse benefits, enhancing physical, mental, and emotional well-being. It improves flexibility and joint health, particularly in older adults, while strength-building styles target both upper and lower limbs. Yoga reduces stress through physical practice, meditation, and breathwork, and research supports its effectiveness in alleviating symptoms of depression and anxiety. Practices like Yoga Nidra are particularly beneficial for anxiety relief.
For individuals with chronic pain, yoga improves quality of life and promotes long-term health benefits. Pranayama (yogic breathing) enhances cardiovascular function and strengthens the immune system by reducing inflammation. Yoga supports better sleep, fosters positive body image, and boosts self-esteem, especially in adolescents and young adults. Regular practice improves brain function, posture, and body awareness, counteracting the effects of poor posture and burnout. By promoting mental calm and resilience, yoga provides a holistic approach to maintaining health and well-being.
Credit: AI image
As Delhi wakes up to another spell of deteriorating air quality just days ahead of Diwali, ophthalmologists warn that dust, smoke, particulate matter, and toxic gases can affect children's eyes, triggering redness, itching, burning, excessive watering, and dryness.
On Tuesday, India's national capital's average Air Quality Index (AQI) climbed to 331 at 7 am, entering the ‘very poor’ category. At the same time, eight monitoring stations recorded readings above 400, falling in the ‘severe’ zone, according to the Central Pollution Control Board (CPCB).
As per data from the CPCB, 33 of the city's 58 monitoring stations recorded AQI levels in the ‘very poor’ category. Meanwhile, the India Meteorological Department (IMD) and the Indian Institute of Tropical Meteorology have forecast that air quality is likely to remain in the ‘very poor’ category over the coming days.
“Children’s eyes are more sensitive to irritants in the environment, and exposure to pollutants, particulate matter and toxic gases can irritate the surface of the eye,” Dr Shibal Bhartiya, Clinical Director – Ophthalmology and Program Director – Community Outreach and Wellness at Marengo Asia International Institute of Neuro and Spine (MAIINS), told HealthandMe.
The experts warned that exposure to pollutants and particulate matter can irritate the surface of children's eyes, causing redness, itching, burning, excessive tearing and dryness.
Dr Neepa Thacker Dave, Senior Consultant in Paediatric Ophthalmology at SRCC Children's Hospital, told HealthandMe that the eye’s surface is protected by a delicate tear film that provides lubrication, maintains clear vision and helps defend against environmental irritants. Exposure to airborne pollutants can disturb this protective layer and contribute to ocular surface irritation and inflammation.
"Excessive watering does not necessarily mean that the eyes are adequately lubricated. Irritation can trigger reflex tearing even when the tear film is unstable. Consequently, children may experience watering alongside dryness or discomfort," she said.
Further, children with existing allergies or sensitive eyes may notice their symptoms worsening during periods of high pollution.
“Long-term exposure to poor air quality may also worsen pre-existing ocular surface conditions,” Dr Bhartiya said.
Read More: Rising AQI In Delhi-NCR: Doctors Warn Of Lung And Heart Risks As Pollution Builds
Reducing children's exposure to pollution is important, particularly on days when air quality is poor.
Dr Bhartiya advised parents to:
Dr Dave also highlighted the importance of greater awareness, reduced exposure and timely medical care in protecting children from pollution-related eye irritation and discomfort.
Dr Dave said children may not always have the vocabulary to describe eye discomfort. Parents and teachers should watch for frequent eye rubbing, excessive blinking, squinting, watering or reluctance to participate in reading and outdoor activities.
Parents should not dismiss eye irritation in children, particularly when pollution levels are high.
Although mild irritation may improve when exposure is reduced, recurring or persistent symptoms warrant an eye examination. Eye pain, significant sensitivity to light, blurred or reduced vision, marked redness or difficulty opening the eye require prompt medical attention.
Credit: iStock
Type 2 diabetes is an incurable but manageable metabolic disorder that affects millions worldwide. But a new clinical trial has shown promise in reversing type 2 diabetes in young adults through intensive diet and exercise. It suggests that more than half younger adults with this condition may be able to achieve remission within six months through a structured programme combining a low-calorie diet with supervised aerobic and strength training.
The study, published in The Lancet Regional Health – Americas, found that 54% of participants who followed the intensive lifestyle programme achieved diabetes remission after 24 weeks. In comparison, only 4% of those receiving usual medical care reached the same outcome.
The research, called the RESET for Remission trial, was led by researchers from McGill University in Canada and the University of Leicester in the UK. It focused on adults with early-onset type 2 diabetes, a form of the disease diagnosed before the age of 45.
Also read: GLP-1 Drugs May Be More Effective Than Metformin At Preventing Diabetes: Study
The trial enrolled 96 adults aged 18 to 45 who had both obesity and type 2 diabetes. Participants were recruited at research centres in Montreal and Edmonton in Canada, and Leicester in the UK. None of them were using insulin.
Of these, 50 were assigned to the intensive diet-and-exercise programme, while 46 received usual medical care. For the first 12 weeks, participants in the intervention group followed a very low-calorie diet providing 800 to 900 calories a day.
During the first two weeks, they consumed meal-replacement products. From weeks three to 12, they could include one structured meal containing lean protein and vegetables alongside the meal replacements.
The programme also included supervised aerobic and resistance training twice a week, along with one independent exercise session each week. For the next 12 weeks, participants followed a healthy diet designed to maintain their weight loss and continued exercising.
Blood sugar and blood pressure medications were stopped at the beginning of the intervention under medical supervision, according to the study protocol.
To qualify for remission, participants had to maintain an HbA1c level below 6.5% without taking medication for at least 12 weeks. HbA1c is a blood test that reflects average blood sugar levels over approximately three months.
Also read: Early Adulthood Obesity Linked To Thyroid, Ovarian And Endometrial Cancers: Study Of 6.3 Million
At the end of 24 weeks, 27 of the 50 participants in the intensive lifestyle group had achieved remission, compared to two of the 46 participants receiving usual care.
After considering relevant factors, researchers found that participants following the intensive programme were 21 times more likely to achieve remission than those receiving standard care.
The intervention group also experienced greater weight loss. Participants with available weight data lost an average of 8.4 kg over 24 weeks, compared to 1.2 kg in the usual care group. After adjustment, the difference in weight loss between the groups was approximately 7.5 kg.
The benefits were not just limited to body weight and blood sugar. MRI scans showed that participants in the intervention group lost more than 9% of their liver fat and more than 24% of their visceral fat, which is the fat stored around internal organs.
Their physical fitness improved, grip strength increased, and blood pressure and resting heart rate declined. Participants also reported fewer symptoms of depressed mood, distress and better quality of life.
One of the important aspects of the programme was its focus on preserving muscle during rapid weight loss. Losing weight through severe calorie restriction can reduce both body fat as well as mass, which includes muscle. Researchers wanted to determine whether adding resistance training could help participants lose fat while maintaining muscle.
Lead author Dr Kaberi Dasgupta, professor of medicine and director of the Division of General Internal Medicine at McGill University, told Fox News Digital, "Our study shows that it is possible to combine a low-calorie diet with supervised exercise in young adults with type 2 diabetes," she said.
"There has previously been some concern about combining the two as being too much of a burden for people. However, people in our study stayed in our study."
Explaining the role of exercise in the results, Dasgupta said, "In our study, we think the diet provoked the weight loss, and exercise helped make sure it was [not] from muscle."
She added, "We were happy and surprised that not only did people lose fat from their organs and liver, our MRI studies indicated their muscle did not decrease at all and their handgrip strength went up."
The researchers also focused on muscle preservation. "Our findings demonstrate the feasibility and efficacy of combining structured aerobic and resistance exercise with a low energy diet in early onset type 2 diabetes, supporting its potential to deliver substantial and holistic health and well-being benefits alongside diabetes remission."
However, the trial did not include a separate group following the low-calorie diet without exercise. Therefore, researchers could not establish how much of the muscle preservation and fitness improvement was specifically due to exercise.
Dasgupta acknowledged this limitation and said, "The main limitation is that we had to compare the diet plus exercise with usual care," she said. "We would have liked to compare diet alone against diet and exercise to perfectly prove the point that the improvements in muscle and fitness were from the exercise."
Credit: AI
Metformin has been long used to manage diabetes. But a major analysis based on more than 256,000 adults with obesity and prediabetes has found that people who take GLP-1 medications like Ozempic and Mounjaro were less likely to develop type 2 diabetes than those taking metformin.
The study also found that people taking GLP-1 medications were more likely to return to normal blood sugar levels and had lower risks of heart attacks, strokes, heart failure and death from any cause compared to those taking metformin.
The findings come from preliminary research presented at the American Heart Association's (AHA) Scientific Sessions 2026. Researchers compared health records of adults to both obesity and prediabetes to examine whether GLP-1 medications could help prevent the progression to type 2 diabetes.
According to the AHA, the analysis included 256,492 adults, with an average age of 52 years. Women accounted for 76% of the participants.
About half of the participants were taking GLP-1-based medications, including semaglutide, tirzepatide, liraglutide and dulaglutide, while the remaining participants were taking metformin.
Researchers used electronic health records from the TriNetX global multicentre network, which included 104 institutions. The records covered the period from 2010 to 2023. The participants were followed for an average of approximately three years.
The researchers matched participants based on factors such as age, existing health conditions, including high blood pressure and sleep apnoea, nicotine dependence and other medications.
Also read: ‘Godzilla’ Drug Retatrutide Reverses Sleep Apnea In 1 In 4 Diabetes Patients
Compared to people on metformin, those taking GLP-1 medications had a 31% lower risk of developing type 2 diabetes.
They were also 1.5 times more likely to return to normal blood sugar levels, suggesting that the medications may help reverse the progression from prediabetes in some people.
The analysis also identified differences in cardiovascular results. Compared to the metformin group, people taking GLP-1 medications had:
The risk of death from any cause was also 41% lower among people taking GLP-1 medications.
Most earlier research on GLP-1 medications has focused on people who already have type 2 diabetes. This analysis examined their benefits at an earlier stage, when blood sugar levels are higher than normal but have enough for a diabetes diagnosis.
Commenting on the findings, study author Vinicius de Sousa Barzon Serra, MD, a research fellow in the Department of Cardiovascular Medicine at Mayo Clinic in Scottsdale, Arizona, said, “The great news with prediabetes is that it’s still possible to reverse the progression of the disease.”
He added, “This research may add to the case for considering GLP-1 medications earlier for certain patients, rather than waiting until they develop Type 2 diabetes.”
However, Serra said the findings do not mean metformin should be replaced by GLP-1 medications.
“The main effect these findings could have is on the shared decision-making discussion between doctors and patients exploring various treatment options, and the pros and cons for each,” he said.
“Metformin is still a first-line treatment choice. It is safe, inexpensive and has a long track record. This is less about replacing one medication with another and more about discussing additional options with specific patients,” he added.
Serra also highlighted the importance of lifestyle changes in preventing diabetes.
“It's important to note that an essential component of prediabetes treatment is lifestyle changes to manage weight, including diet and exercise and considering medications, including metformin, based on each individual's overall health and any other medical conditions,” he said.
Robert Eckel, MD, FAHA, a former volunteer president of the American Heart Association and professor of medicine emeritus at the University of Colorado Anschutz Medical Campus, said the findings were not surprising. “The benefits noted in this study likely relates to the patients losing weight, which is known to help prevent Type 2 diabetes,” said Eckel.
He explained that preventing the progression from prediabetes to type 2 diabetes could also help reduce cardiovascular complications.
“Preventing the progression from pre-diabetes to Type 2 diabetes keeps patients from having Type 2 diabetes, and it also helps prevent heart attack and strokes,” he said.
Eckel added, “GLP-1s provide another option for prevention, perhaps as an add-on therapy. However, costs and access to these medications are important factors.”
The findings should not be interpreted as evidence that Ozempic or Mounjaro is superior to metformin for every person with prediabetes.
The American Diabetes Association's 2026 Standards of Care identify metformin as an option for people at particularly high risk of developing type 2 diabetes, including adults aged 25 to 59 years with a BMI of 35 or higher, higher blood glucose levels or a history of gestational diabetes.
The guidelines also say that metformin has the most robust evidence for pharmacological diabetes prevention. While GLP-1-based therapies can be considered for weight management in people with overweight or obesity, long-term evidence does not currently support using glucose-lowering medications other than metformin solely for the purpose of preventing type 2 diabetes.
© $2026 Times Horizon Private Limited